HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Angelalign Technology (6699.HK) - About the Share Price Rebound, the Outlook and the Challenges

Pre-IPO CanSino Biologics - 2022 Annual Results May Be Ugly as MCV4 Commercialization Hit a Snag

Pre-IPO New Ruipeng Pet Group (RPET.US)- The Industry, the Business and the Concerns

Modern Dental Group (3600.HK) - More Suitable for Short Term Trading than Long Term Holding

Jinxin Fertility Co Ltd (1951.HK) - Hard to Achieve Performance Reversal in 2023

Modern Dental Group (3600.HK) 22H1- Share Price May Remain Tepid Due to Lack of Core Competitiveness

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/modern-dental-group-ltd" target="_blank" data-smartkarma-citation="entities:21020:1" rel="noopener">Modern Dental Group</a> (MDG) disclosed selected unaudited operational data for 22Q1-Q3. The negative trend on performance would continue to 22Q4. The overall 2022 performance of MDG would show a negative growth.</li>
<li>We may face a situation where both domestic and external demand would weaken in 2023. MDG’s overseas revenue is expected to see a bigger YoY decline than domestic revenue.</li>
<li>There would be strong expectations but weak realities in 2023Q1-Q2, during which MDG's share price could rally in short term, but it’s not based on the improvement of its fundamentals.</li>
</ul>



Modern Dental Group (MDG) disclosed selected unaudited operational data for 22Q1-Q3. The negative trend on performance would continue to 22Q4. The overall 2022 performance of MDG would show a negative growth.
We may face a situation where both domestic and external demand would weaken in 2023. MDG’s overseas revenue is expected to see a bigger YoY decline than domestic revenue.
There would be strong expectations but weak realities in 2023Q1-Q2, during which MDG's share price could rally in short term, but it’s not based on the improvement of its fundamentals.


Modern Dental Group (3600.HK)- 2023 Harsh Reality Is Hard to Avoid, but Short-Term Rally Is Possible